Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07317050Phase 3Not Yet Recruiting

Clinical Trial With Aprotinin in the Acute Respiratory Distress Syndrome Treatment

Role: lead

NCT03696654Not ApplicableActive Not Recruiting

High Blood Pressure in Paediatric Patients With Sleep Disorder Breathing.

Role: lead

NCT05210166Not ApplicableCompleted

Transcutaneous Spinal Cord Stimulation and Robotic Therapy

Role: collaborator

NCT04717947Unknown

Interval Between Neoadjuvant Therapy and Surgery in the Treatment of Locally Advanced Rectal Cancer (CRONOS)

Role: collaborator

All 4 trials loaded